Plasma pharmacokinetic parameters
Dose (mg/kg/d)/ patient ID no. . | Age, y . | Dose, mg/day . | AsIII AUC0-24h, μM-h . | Total Arsenic . | Ratio of AsIII to total AUC0-24 . | ||||
---|---|---|---|---|---|---|---|---|---|
AUC0-24h, μM-h . | Cmaxμm . | Before dose 2 μm . | Before dose 5 μm . | Before dose 20 μm . | |||||
0.07, 18* | 19 | 8.82 | 0.83 | 1.67 | 0.27 | 0.07 | 0.18 | 0.25 | 0.50 |
0.1, 20*0.15 | 19 | 10 | 0.70 | 2.00 | 0.23 | 0.06 | 0.10 | 0.27 | 0.35 |
1 | 17 | 14.8 | 2.06 | 3.23 | 0.22 | 0.10 | 0.26 | 0.39 | 0.64 |
2 | 13 | 5.8 | 1.90 | 3.00 | 0.21 | 0.11 | ND | ND | 0.63 |
4 | 14 | 10 | 1.80 | 2.89 | 0.26 | 0.11 | <LLQ | <LLQ | 0.62 |
5 | 9 | 3.8 | 1.84 | 3.44 | 0.37 | 0.12 | 0.21 | ND | 0.54 |
6 | 18 | 7.9 | 2.12 | 1.77 | 0.30 | 0.03 | 0.12 | ND | 1.22 |
10 | 17 | 7.9 | 2.75 | 3.85 | 0.26 | 0.17 | 0.35 | ND | 0.71 |
16 | 20 | 11 | 0.46 | 1.46 | 0.11 | 0.07 | 0.19 | 0.32 | 0.31 |
17 | 5 | 3.3 | 1.14 | 1.85 | 0.24 | 0.04 | ND | ND | 0.62 |
19 | 4 | 2.9 | 1.12 | 2.58 | 0.27 | 0.11 | 0.18 | 0.26 | 0.43 |
22 | 12 | 6 | 1.17 | 2.42 | 0.28 | 0.07 | 0.20 | 0.24 | 0.48 |
Median | 13.5 | 7.0 | 1.82 | 2.74 | 0.26 | 0.11 | 0.20 | 0.26 | 0.62 |
Range | 4-20 | 2.9-14.8 | 0.46-2.75 | 1.46-3.85 | 0.11-0.37 | 0.03-0.12 | 0-0.35 | 0-0.39 | 0.31-1.22 |
0.2 | |||||||||
8 | 16 | 12 | 2.72 | 4.77 | 0.40 | 0.16 | 0.58 | ND | 0.57 |
9 | 3 | 3.08 | 2.77 | 4.37 | 0.46 | 0.12 | 0.25 | 0.35 | 0.63 |
Dose (mg/kg/d)/ patient ID no. . | Age, y . | Dose, mg/day . | AsIII AUC0-24h, μM-h . | Total Arsenic . | Ratio of AsIII to total AUC0-24 . | ||||
---|---|---|---|---|---|---|---|---|---|
AUC0-24h, μM-h . | Cmaxμm . | Before dose 2 μm . | Before dose 5 μm . | Before dose 20 μm . | |||||
0.07, 18* | 19 | 8.82 | 0.83 | 1.67 | 0.27 | 0.07 | 0.18 | 0.25 | 0.50 |
0.1, 20*0.15 | 19 | 10 | 0.70 | 2.00 | 0.23 | 0.06 | 0.10 | 0.27 | 0.35 |
1 | 17 | 14.8 | 2.06 | 3.23 | 0.22 | 0.10 | 0.26 | 0.39 | 0.64 |
2 | 13 | 5.8 | 1.90 | 3.00 | 0.21 | 0.11 | ND | ND | 0.63 |
4 | 14 | 10 | 1.80 | 2.89 | 0.26 | 0.11 | <LLQ | <LLQ | 0.62 |
5 | 9 | 3.8 | 1.84 | 3.44 | 0.37 | 0.12 | 0.21 | ND | 0.54 |
6 | 18 | 7.9 | 2.12 | 1.77 | 0.30 | 0.03 | 0.12 | ND | 1.22 |
10 | 17 | 7.9 | 2.75 | 3.85 | 0.26 | 0.17 | 0.35 | ND | 0.71 |
16 | 20 | 11 | 0.46 | 1.46 | 0.11 | 0.07 | 0.19 | 0.32 | 0.31 |
17 | 5 | 3.3 | 1.14 | 1.85 | 0.24 | 0.04 | ND | ND | 0.62 |
19 | 4 | 2.9 | 1.12 | 2.58 | 0.27 | 0.11 | 0.18 | 0.26 | 0.43 |
22 | 12 | 6 | 1.17 | 2.42 | 0.28 | 0.07 | 0.20 | 0.24 | 0.48 |
Median | 13.5 | 7.0 | 1.82 | 2.74 | 0.26 | 0.11 | 0.20 | 0.26 | 0.62 |
Range | 4-20 | 2.9-14.8 | 0.46-2.75 | 1.46-3.85 | 0.11-0.37 | 0.03-0.12 | 0-0.35 | 0-0.39 | 0.31-1.22 |
0.2 | |||||||||
8 | 16 | 12 | 2.72 | 4.77 | 0.40 | 0.16 | 0.58 | ND | 0.57 |
9 | 3 | 3.08 | 2.77 | 4.37 | 0.46 | 0.12 | 0.25 | 0.35 | 0.63 |
These patients were treated at the 0.15 mg/kg/day dose level using ideal body weight to calculate the dose rather than the actual weight. Doses shown represent the dose per actual body weight.
ND indicates sample not drawn; and <LLQ, less than lower limit of quantification